These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15026810)

  • 41. A new reproducible model of hepatic and peritoneal metastases from colonic carcinoma.
    Archer SG; Gray BN
    Eur J Cancer Clin Oncol; 1988 Oct; 24(10):1623-32. PubMed ID: 3208807
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A new intraperitoneal tumor model in the rat.
    Nagel JD; Los G; Begg AC; McVie JG
    Cancer Chemother Pharmacol; 1990; 27(2):121-4. PubMed ID: 2249326
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bioluminescence Imaging for Evaluation of Antitumor Effect In Vitro and In Vivo in Mice Xenografted Tumor Models.
    Sato K
    Methods Mol Biol; 2022; 2524():307-315. PubMed ID: 35821482
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Optimizing bioluminescence imaging to study protozoan parasite infections.
    Taylor MC; Kelly JM
    Trends Parasitol; 2014 Apr; 30(4):161-2. PubMed ID: 24485045
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Non-invasive imaging of implanted peritoneal carcinomatosis in mice using PET and bioluminescence imaging.
    Stollfuss J; Landvogt N; Abenstein M; Ziegler S; Schwaiger M; Senekowitsch-Schmidtke R; Wieder H
    EJNMMI Res; 2015 Dec; 5(1):125. PubMed ID: 26337805
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Non-Invasive Imaging and Scoring of Peritoneal Metastases in Small Preclinical Animal Models Using Ultrasound: A Preliminary Trial.
    Helderman RFCPA; Restrepo MT; Rodermond HM; Bochove GGWV; Löke DR; Franken NAP; Kok HP; Tanis PJ; Crezee J; Oei AL
    Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35884917
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bioluminescence imaging in vivo - application to cancer research.
    Söling A; Rainov NG
    Expert Opin Biol Ther; 2003 Oct; 3(7):1163-72. PubMed ID: 14519079
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Magnetic resonance imaging in cancer research.
    Ross BD; Chenevert TL; Rehemtulla A
    Eur J Cancer; 2002 Nov; 38(16):2147-56. PubMed ID: 12387840
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of Nonradiative Clinical Imaging Techniques for the Longitudinal Assessment of Tumour Growth in Murine CT26 Colon Carcinoma.
    Seguin J; Doan BT; Latorre Ossa H; Jugé L; Gennisson JL; Tanter M; Scherman D; Chabot GG; Mignet N
    Int J Mol Imaging; 2013; 2013():983534. PubMed ID: 23936648
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mouse models and mouse supermodels.
    Curran T
    EMBO Mol Med; 2010 Oct; 2(10):385-6; author reply 386-7. PubMed ID: 20721989
    [No Abstract]   [Full Text] [Related]  

  • 51. The effect of the length of time tumour cells spend in suspension on their ability to establish growths in host rats.
    HADDEN DR
    Ulster Med J; 1960 Dec; 29(2):158-62. PubMed ID: 13710319
    [No Abstract]   [Full Text] [Related]  

  • 52. Experimental study of the course and regulation of tumour growth.
    FOULDS L
    Ann R Coll Surg Engl; 1951 Aug; 9(2):93-101. PubMed ID: 14857648
    [No Abstract]   [Full Text] [Related]  

  • 53. Erratum: Cellular Bioluminescence Imaging.
    Welsh DK; Noguchi T
    Cold Spring Harb Protoc; 2016 Mar; 2016(3):pdb.err091751. PubMed ID: 26933240
    [No Abstract]   [Full Text] [Related]  

  • 54. OBSERVE: guidelines for the refinement of rodent cancer models.
    De Vleeschauwer SI; van de Ven M; Oudin A; Debusschere K; Connor K; Byrne AT; Ram D; Rhebergen AM; Raeves YD; Dahlhoff M; Dangles-Marie V; Hermans ER
    Nat Protoc; 2024 Sep; 19(9):2571-2596. PubMed ID: 38992214
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Photoacoustic imaging for investigating tumor hypoxia: a strategic assessment.
    Nasri D; Manwar R; Kaushik A; Er EE; Avanaki K
    Theranostics; 2023; 13(10):3346-3367. PubMed ID: 37351178
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sorafenib Nanomicelles Effectively Shrink Tumors by Vaginal Administration for Preoperative Chemotherapy of Cervical Cancer.
    Wang J; Lv F; Sun T; Zhao S; Chen H; Liu Y; Liu Z
    Nanomaterials (Basel); 2021 Dec; 11(12):. PubMed ID: 34947619
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Factors Influencing Luciferase-Based Bioluminescent Imaging in Preclinical Models of Brain Tumor.
    Kim M; Gupta SK; Zhang W; Talele S; Mohammad AS; Laramy J; Mladek AC; Zhang S; Sarkaria JN; Elmquist WF
    Drug Metab Dispos; 2022 Mar; 50(3):277-286. PubMed ID: 34887255
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tumor models to assess immune response and tumor-microbiome interactions in colorectal cancer.
    Yuan C; Zhao X; Wangmo D; Alshareef D; Gates TJ; Subramanian S
    Pharmacol Ther; 2022 Mar; 231():107981. PubMed ID: 34480964
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Spectral photon-counting CT imaging of colorectal peritoneal metastases: initial experience in rats.
    Thivolet A; Si-Mohamed S; Bonnot PE; Blanchet C; Képénékian V; Boussel L; Douek P; Rousset P
    Sci Rep; 2020 Aug; 10(1):13394. PubMed ID: 32770125
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of implantation sites for the development of peritoneal metastasis in a colorectal cancer mouse model using non-invasive bioluminescence imaging.
    Taibi A; Albouys J; Jacques J; Perrin ML; Yardin C; Durand Fontanier S; Bardet SM
    PLoS One; 2019; 14(7):e0220360. PubMed ID: 31365553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.